GeneDx Hldgs Q3 Adj EPS $(1.22) Beats $(1.31) Estimate, Sales $53.30M Beat $52.41M Estimate
GeneDx Holdings Corp Ordinary Shares - Class A +2.65% Post
GeneDx Holdings Corp Ordinary Shares - Class A WGS | 79.45 79.45 | +2.65% 0.00% Post |
GeneDx Hldgs (NASDAQ:
WGS) reported quarterly losses of $(1.22) per share which beat the analyst consensus estimate of $(1.31) by 6.87 percent. This is a 81.52 percent increase over losses of $(6.60) per share from the same period last year. The company reported quarterly sales of $53.30 million which beat the analyst consensus estimate of $52.41 million by 1.70 percent. This is a 35.96 percent decrease over sales of $83.23 million the same period last year.
